UK Registered Veterinary Retailer

Dronspot Wormer For Cats

Dronspot Wormer For Cats
Large Cat » 1 Pipette
Medium Cat » 1 Pipette

  • Large Cat » 1 Pipette £7.00
  • Medium Cat » 1 Pipette £7.00
  • Small Cat » 1 Pipette £5.50

Selection of 3 products from

£5.50 to £7.00

Description

Dronspot is a spot on worming treatment for cats. Intestinal worms can easily be picked up by your cat from eating microscopic worm eggs from the environment, from hunting or from swallowing infected fleas when grooming. Kittens can even pick roundworms up from their mum when they suckle her milk.

Dronspot takes the stress out of the worming routine. It’s a simple treatment that is applied at least once every three months to keep worms at bay.

Key features:

  • Spot-on treatment for prevention and treatment of worms in cats
  • Use once every 3 months to keep your cat worm free
  • Easy application, no tablets.

Need help or advice? Contact us:

  • Landline: 01582 842096
  • Mon - Fri: 8:30am - 5:00pm
  • Sat: 9:00am - 1:00pm (Collections only)
  • Email: [email protected]

All prices include VAT where applicable.

Medication Datasheets

Small Cat » 1 Pipette

Dronspot Spot-on Solution

Presentation

Dronspot spot-on solution for cats is a clear yellow to brown solution. The product is presented in a single use plastic tube for dermal (spot-on) application.

Dronspot spot-on solution for small cats is a 0.35 ml tube containing 7.5 mg emodepside and 30 mg praziquantel with 1.89 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for medium cats is a 0.70 ml tube containing 15 mg emodepside and 60 mg praziquantel with 3.78 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for large cats is a 1.12 ml tube containing 24 mg emodepside and 96 mg praziquantel with 6.05 mg Butylhydroxyanisole (E320; as antioxidant).

Uses

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

Roundworms (Nematodes)

Tapeworms (Cestodes)

Dosage and administration

Dosage and Treatment Schedule

See Table 1.

The recommended minimum doses are 3 mg emodepside/kg body weight and 12 mg praziquantel/kg body weight, equivalent to 0.14 ml Dronspot/kg body weight.

For the treatment of roundworms and tapeworms a single administration per treatment is effective.

For the treatment of queens to prevent lactogenic transmission of Toxocara cati (L3 larvae) to the offspring, a single administration per treatment approximately seven days prior to expected birthing is effective.

Method of administration

For external use only.

The cat should be accurately weighed prior to treatment to ensure that the correct pipette size is used.

Remove one pipette from package. Hold pipette in upright position, twist and pull off cap and use the opposite end of the cap to break the seal. See Figure 1.

Figure 1: Opening a pipette

Part the fur on the cat’s neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. Application on the base of the skull will minimise the ability of the cat to lick the product off. See Figure 2.

Figure 2: Administration

Dronspot can be used during pregnancy and lactation.

Contra-indications, warnings, etc

Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.

Do not use in known cases of hypersensitivity to the active substances or to any of the excipients.

Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. Treated animals therefore should not be bathed until the solution has dried.

Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

Apply only to the skin surface and on intact skin. Do not administer orally or parenterally.

Avoid the treated cat or other cats in the household licking the site of application while it is wet.

There is limited experience on the use of the product in sick and debilitated animals. Therefore the product should not be administered to these animals.

Salivation (drooling) and vomiting may occur in very rare cases. Mild and transient neurological disorders such as ataxia (unsteady or stumbling gait) or tremor may occur in very rare cases. These effects are thought to occur as a result of the cat licking the application site immediately after treatment. In very rare cases following administration of the product transient alopecia (hair loss), pruritus (itchiness) and/or inflammation were observed at the application site.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)

- common (more than 1 but less than 10 animals in 100 animals)

- uncommon (more than 1 but less than 10 animals in 1,000 animals)

- rare (more than 1 but less than 10 animals in 10,000 animals)

- very rare (less than 1 animal in 10,000 animals, including isolated reports).

Salivation, vomiting and neurological signs (tremor) were observed occasionally when the product was administered at up to 10 times the recommended dose in adult cats and up to 5 times the recommended dose in kittens. These symptoms were thought to occur as a result of the cat licking the application site. The symptoms were completely reversible. There is no known specific antidote.

Emodepside is a substrate for P-glycoprotein. Co-treatment with other drugs that are P-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and cyclosporine) could give rise to pharmacokinetic drug interactions. The potential clinical consequences of such interactions have not been investigated. If your cat is receiving any medications, please contact your vet to discuss this before applying the product. Similarly, please inform your vet that you are using this product if s/he provides your cat with any medication.

The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.

Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.

Read the package leaflet before use.

Do not smoke, eat or drink during application.

Avoid direct contact with application area while it is wet. Keep children away from treated animals during that time.

Wash hands after use.

In case of accidental spillage onto skin, wash off immediately with soap and water.

If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water.

If skin or eye symptoms persist, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Care should be taken not to allow children to have prolonged intensive contact (for example, by sleeping) with treated cats during the first 24 hours after application of the product.

The veterinary medicinal product should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Pharmaceutical precautions

Shelf life of the veterinary medicinal product as packaged for sale: 3 years

Store in the original package in order to protect from moisture.

Store below 25°C

Legal category

Packaging quantities

White polypropylene pipettes with caps in aluminium blisters. Blister packs containing 2 or 20 unit dose pipettes.

Further information

Pharmacotherapeutic group: therapeutic antiparasitic agent; ATCvet code: QP52AA51.

Emodepside is a semi-synthetic compound belonging to the new chemical group of depsipeptides. It is active against roundworms (ascarids and hookworms). In this product, emodepside is responsible for the efficacy against Toxocara cati, Toxascaris leonina, Ancylostoma tubaeforme and Aelurostrongylus abstrusus.

It acts at the neuromuscular junction by stimulating presynaptic receptors belonging to the secretin receptor family which results in paralysis and death of the parasites.

Praziquantel is a pyrazinoisoquinoline derivative effective against tapeworms such as Dipylidium caninum, Echinococcus multilocularis, and Taenia taeniaeformis.

Praziquantel is rapidly absorbed via the surface of the parasites and acts primarily by changing the Ca++ permeability of the parasite membranes. This results in severe damage to the parasite integument, contraction and paralysis, disruption of metabolism and finally leads to the death of the parasite.

After topical application of this product to cats at the minimum therapeutic dose of 0.14 ml/kg bodyweight, mean maximum serum concentrations of 32.2 ± 23.9 µg emodepside/l and 61.3 ± 44.1 µg praziquantel/l were observed. Maximum concentrations were reached for emodepside 3.2 ± 2.7 days after application and 18.7 ± 47 hours for praziquantel. Both active substances are then slowly eliminated from the serum with a half-life of 9.2 ± 3.9 days for emodepside and 4.1 ± 1.5 days for praziquantel.

After oral application in the rat, emodepside is distributed to all organs. Highest concentration levels are found in the fat. Faecal excretion predominates with unchanged emodepside and hydroxylated derivatives as the major excretion products.

Studies in many different species show that praziquantel is rapidly metabolised in the liver. The main metabolites are monohydroxycyclohexyl derivatives of praziquantel. Renal elimination predominates.

Marketing Authorisation Holder (if different from distributor)

Marketing Authorisation Number

Vm 00010/4211Vm 00010/4212Vm 00010/4213

Vm 00010/4211

Vm 00010/4212

Vm 00010/4213

Medium Cat » 1 Pipette

Dronspot Spot-on Solution

Presentation

Dronspot spot-on solution for cats is a clear yellow to brown solution. The product is presented in a single use plastic tube for dermal (spot-on) application.

Dronspot spot-on solution for small cats is a 0.35 ml tube containing 7.5 mg emodepside and 30 mg praziquantel with 1.89 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for medium cats is a 0.70 ml tube containing 15 mg emodepside and 60 mg praziquantel with 3.78 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for large cats is a 1.12 ml tube containing 24 mg emodepside and 96 mg praziquantel with 6.05 mg Butylhydroxyanisole (E320; as antioxidant).

Uses

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

Roundworms (Nematodes)

Tapeworms (Cestodes)

Dosage and administration

Dosage and Treatment Schedule

See Table 1.

The recommended minimum doses are 3 mg emodepside/kg body weight and 12 mg praziquantel/kg body weight, equivalent to 0.14 ml Dronspot/kg body weight.

For the treatment of roundworms and tapeworms a single administration per treatment is effective.

For the treatment of queens to prevent lactogenic transmission of Toxocara cati (L3 larvae) to the offspring, a single administration per treatment approximately seven days prior to expected birthing is effective.

Method of administration

For external use only.

The cat should be accurately weighed prior to treatment to ensure that the correct pipette size is used.

Remove one pipette from package. Hold pipette in upright position, twist and pull off cap and use the opposite end of the cap to break the seal. See Figure 1.

Figure 1: Opening a pipette

Part the fur on the cat’s neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. Application on the base of the skull will minimise the ability of the cat to lick the product off. See Figure 2.

Figure 2: Administration

Dronspot can be used during pregnancy and lactation.

Contra-indications, warnings, etc

Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.

Do not use in known cases of hypersensitivity to the active substances or to any of the excipients.

Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. Treated animals therefore should not be bathed until the solution has dried.

Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

Apply only to the skin surface and on intact skin. Do not administer orally or parenterally.

Avoid the treated cat or other cats in the household licking the site of application while it is wet.

There is limited experience on the use of the product in sick and debilitated animals. Therefore the product should not be administered to these animals.

Salivation (drooling) and vomiting may occur in very rare cases. Mild and transient neurological disorders such as ataxia (unsteady or stumbling gait) or tremor may occur in very rare cases. These effects are thought to occur as a result of the cat licking the application site immediately after treatment. In very rare cases following administration of the product transient alopecia (hair loss), pruritus (itchiness) and/or inflammation were observed at the application site.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)

- common (more than 1 but less than 10 animals in 100 animals)

- uncommon (more than 1 but less than 10 animals in 1,000 animals)

- rare (more than 1 but less than 10 animals in 10,000 animals)

- very rare (less than 1 animal in 10,000 animals, including isolated reports).

Salivation, vomiting and neurological signs (tremor) were observed occasionally when the product was administered at up to 10 times the recommended dose in adult cats and up to 5 times the recommended dose in kittens. These symptoms were thought to occur as a result of the cat licking the application site. The symptoms were completely reversible. There is no known specific antidote.

Emodepside is a substrate for P-glycoprotein. Co-treatment with other drugs that are P-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and cyclosporine) could give rise to pharmacokinetic drug interactions. The potential clinical consequences of such interactions have not been investigated. If your cat is receiving any medications, please contact your vet to discuss this before applying the product. Similarly, please inform your vet that you are using this product if s/he provides your cat with any medication.

The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.

Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.

Read the package leaflet before use.

Do not smoke, eat or drink during application.

Avoid direct contact with application area while it is wet. Keep children away from treated animals during that time.

Wash hands after use.

In case of accidental spillage onto skin, wash off immediately with soap and water.

If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water.

If skin or eye symptoms persist, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Care should be taken not to allow children to have prolonged intensive contact (for example, by sleeping) with treated cats during the first 24 hours after application of the product.

The veterinary medicinal product should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Pharmaceutical precautions

Shelf life of the veterinary medicinal product as packaged for sale: 3 years

Store in the original package in order to protect from moisture.

Store below 25°C

Legal category

Packaging quantities

White polypropylene pipettes with caps in aluminium blisters. Blister packs containing 2 or 20 unit dose pipettes.

Further information

Pharmacotherapeutic group: therapeutic antiparasitic agent; ATCvet code: QP52AA51.

Emodepside is a semi-synthetic compound belonging to the new chemical group of depsipeptides. It is active against roundworms (ascarids and hookworms). In this product, emodepside is responsible for the efficacy against Toxocara cati, Toxascaris leonina, Ancylostoma tubaeforme and Aelurostrongylus abstrusus.

It acts at the neuromuscular junction by stimulating presynaptic receptors belonging to the secretin receptor family which results in paralysis and death of the parasites.

Praziquantel is a pyrazinoisoquinoline derivative effective against tapeworms such as Dipylidium caninum, Echinococcus multilocularis, and Taenia taeniaeformis.

Praziquantel is rapidly absorbed via the surface of the parasites and acts primarily by changing the Ca++ permeability of the parasite membranes. This results in severe damage to the parasite integument, contraction and paralysis, disruption of metabolism and finally leads to the death of the parasite.

After topical application of this product to cats at the minimum therapeutic dose of 0.14 ml/kg bodyweight, mean maximum serum concentrations of 32.2 ± 23.9 µg emodepside/l and 61.3 ± 44.1 µg praziquantel/l were observed. Maximum concentrations were reached for emodepside 3.2 ± 2.7 days after application and 18.7 ± 47 hours for praziquantel. Both active substances are then slowly eliminated from the serum with a half-life of 9.2 ± 3.9 days for emodepside and 4.1 ± 1.5 days for praziquantel.

After oral application in the rat, emodepside is distributed to all organs. Highest concentration levels are found in the fat. Faecal excretion predominates with unchanged emodepside and hydroxylated derivatives as the major excretion products.

Studies in many different species show that praziquantel is rapidly metabolised in the liver. The main metabolites are monohydroxycyclohexyl derivatives of praziquantel. Renal elimination predominates.

Marketing Authorisation Holder (if different from distributor)

Marketing Authorisation Number

Vm 00010/4211Vm 00010/4212Vm 00010/4213

Vm 00010/4211

Vm 00010/4212

Vm 00010/4213

Large Cat » 1 Pipette

Dronspot Spot-on Solution

Presentation

Dronspot spot-on solution for cats is a clear yellow to brown solution. The product is presented in a single use plastic tube for dermal (spot-on) application.

Dronspot spot-on solution for small cats is a 0.35 ml tube containing 7.5 mg emodepside and 30 mg praziquantel with 1.89 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for medium cats is a 0.70 ml tube containing 15 mg emodepside and 60 mg praziquantel with 3.78 mg Butylhydroxyanisole (E320; as antioxidant).

Dronspot spot-on solution for large cats is a 1.12 ml tube containing 24 mg emodepside and 96 mg praziquantel with 6.05 mg Butylhydroxyanisole (E320; as antioxidant).

Uses

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

Roundworms (Nematodes)

Tapeworms (Cestodes)

Dosage and administration

Dosage and Treatment Schedule

See Table 1.

The recommended minimum doses are 3 mg emodepside/kg body weight and 12 mg praziquantel/kg body weight, equivalent to 0.14 ml Dronspot/kg body weight.

For the treatment of roundworms and tapeworms a single administration per treatment is effective.

For the treatment of queens to prevent lactogenic transmission of Toxocara cati (L3 larvae) to the offspring, a single administration per treatment approximately seven days prior to expected birthing is effective.

Method of administration

For external use only.

The cat should be accurately weighed prior to treatment to ensure that the correct pipette size is used.

Remove one pipette from package. Hold pipette in upright position, twist and pull off cap and use the opposite end of the cap to break the seal. See Figure 1.

Figure 1: Opening a pipette

Part the fur on the cat’s neck at the base of the skull until the skin is visible. Place the tip of the pipette on the skin and squeeze firmly several times to empty the contents directly onto the skin. Application on the base of the skull will minimise the ability of the cat to lick the product off. See Figure 2.

Figure 2: Administration

Dronspot can be used during pregnancy and lactation.

Contra-indications, warnings, etc

Do not use in kittens under 8 weeks of age or weighing less than 0.5 kg.

Do not use in known cases of hypersensitivity to the active substances or to any of the excipients.

Shampooing or immersion of the animal in water directly after treatment may reduce the efficacy of the product. Treated animals therefore should not be bathed until the solution has dried.

Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.

Apply only to the skin surface and on intact skin. Do not administer orally or parenterally.

Avoid the treated cat or other cats in the household licking the site of application while it is wet.

There is limited experience on the use of the product in sick and debilitated animals. Therefore the product should not be administered to these animals.

Salivation (drooling) and vomiting may occur in very rare cases. Mild and transient neurological disorders such as ataxia (unsteady or stumbling gait) or tremor may occur in very rare cases. These effects are thought to occur as a result of the cat licking the application site immediately after treatment. In very rare cases following administration of the product transient alopecia (hair loss), pruritus (itchiness) and/or inflammation were observed at the application site.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)

- common (more than 1 but less than 10 animals in 100 animals)

- uncommon (more than 1 but less than 10 animals in 1,000 animals)

- rare (more than 1 but less than 10 animals in 10,000 animals)

- very rare (less than 1 animal in 10,000 animals, including isolated reports).

Salivation, vomiting and neurological signs (tremor) were observed occasionally when the product was administered at up to 10 times the recommended dose in adult cats and up to 5 times the recommended dose in kittens. These symptoms were thought to occur as a result of the cat licking the application site. The symptoms were completely reversible. There is no known specific antidote.

Emodepside is a substrate for P-glycoprotein. Co-treatment with other drugs that are P-glycoprotein substrates/inhibitors (for example, ivermectin and other antiparasitic macrocyclic lactones, erythromycin, prednisolone and cyclosporine) could give rise to pharmacokinetic drug interactions. The potential clinical consequences of such interactions have not been investigated. If your cat is receiving any medications, please contact your vet to discuss this before applying the product. Similarly, please inform your vet that you are using this product if s/he provides your cat with any medication.

The solvent in this product may stain certain materials including leather, fabrics, plastics and finished surfaces. Allow the application site to dry before permitting contact with such materials.

Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease to the OIE, specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.

Read the package leaflet before use.

Do not smoke, eat or drink during application.

Avoid direct contact with application area while it is wet. Keep children away from treated animals during that time.

Wash hands after use.

In case of accidental spillage onto skin, wash off immediately with soap and water.

If the product accidentally gets into eyes, they should be thoroughly flushed with plenty of water.

If skin or eye symptoms persist, or in case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.

Care should be taken not to allow children to have prolonged intensive contact (for example, by sleeping) with treated cats during the first 24 hours after application of the product.

The veterinary medicinal product should not be allowed to enter water courses as emodepside has shown harmful effects on aquatic organisms.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Pharmaceutical precautions

Shelf life of the veterinary medicinal product as packaged for sale: 3 years

Store in the original package in order to protect from moisture.

Store below 25°C

Legal category

Packaging quantities

White polypropylene pipettes with caps in aluminium blisters. Blister packs containing 2 or 20 unit dose pipettes.

Further information

Pharmacotherapeutic group: therapeutic antiparasitic agent; ATCvet code: QP52AA51.

Emodepside is a semi-synthetic compound belonging to the new chemical group of depsipeptides. It is active against roundworms (ascarids and hookworms). In this product, emodepside is responsible for the efficacy against Toxocara cati, Toxascaris leonina, Ancylostoma tubaeforme and Aelurostrongylus abstrusus.

It acts at the neuromuscular junction by stimulating presynaptic receptors belonging to the secretin receptor family which results in paralysis and death of the parasites.

Praziquantel is a pyrazinoisoquinoline derivative effective against tapeworms such as Dipylidium caninum, Echinococcus multilocularis, and Taenia taeniaeformis.

Praziquantel is rapidly absorbed via the surface of the parasites and acts primarily by changing the Ca++ permeability of the parasite membranes. This results in severe damage to the parasite integument, contraction and paralysis, disruption of metabolism and finally leads to the death of the parasite.

After topical application of this product to cats at the minimum therapeutic dose of 0.14 ml/kg bodyweight, mean maximum serum concentrations of 32.2 ± 23.9 µg emodepside/l and 61.3 ± 44.1 µg praziquantel/l were observed. Maximum concentrations were reached for emodepside 3.2 ± 2.7 days after application and 18.7 ± 47 hours for praziquantel. Both active substances are then slowly eliminated from the serum with a half-life of 9.2 ± 3.9 days for emodepside and 4.1 ± 1.5 days for praziquantel.

After oral application in the rat, emodepside is distributed to all organs. Highest concentration levels are found in the fat. Faecal excretion predominates with unchanged emodepside and hydroxylated derivatives as the major excretion products.

Studies in many different species show that praziquantel is rapidly metabolised in the liver. The main metabolites are monohydroxycyclohexyl derivatives of praziquantel. Renal elimination predominates.

Marketing Authorisation Holder (if different from distributor)

Marketing Authorisation Number

Vm 00010/4211Vm 00010/4212Vm 00010/4213

Vm 00010/4211

Vm 00010/4212

Vm 00010/4213

Delivery Information

How quickly do you deliver?

Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.

What do you charge for delivery?

For UK delivery, we charge the following:

Order Total Weight Delivery
£0-£28.99 Under 2kg £2.99
2kg+ £4.99
£29-£38.99 Under 2kg Free
2kg+ £4.99
£39+ Under 2kg Free
2kg+ Free

Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.

For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.

We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.

Delivery of aerosols

Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.

Delivery of temperature controlled items

Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.

How do I cancel or return an order?

Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.

To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.

*For full details on returns, see our terms and conditions page.

Reviews (18)

Q & A

Below are some recent questions we've received regarding Dronspot Wormer For Cats, including answers from our team.

31 October 2018 at 7:39am

Does it eradicate all types of worms?

Janet Bell

I understood that the spot on type of wormer only works for one type of intestinal worms which can infect cats. Can you confirm that it will eradicate all the types of worms in cats, as per the tablet type of wormer.

  • Veterinary Advisor

Dronspot is effective against roundworm and tapeworm. It kills every type of intestinal worm commonly found in UK cats.

30 October 2018 at 8:31pm

Tapeworm

Bianca Kubler

  • VioVet customer since 2015
  • From: Hertfordshire, United Kingdom

I use Droncit for my cats for tapeworm and alternate with Panacur powder every three months. Does this new product deal with tapeworm or will I still need to use Droncit?

  • Veterinary Advisor

Dronspot is effective against roundworm and tapeworm.

30 October 2018 at 8:17pm

Weight

Stella Parr

What weight range would you define as small, medium and large cats please?

  • Veterinary Advisor

Small: 0.5-2.5kg

Medium: 2.5-5kg

Large: 5-8kg

26 October 2018 at 3:50pm

Age

Emma

What age can you use this from?

  • Customer Service Advisor

Hello,

Thank you for your message.

This is suitable for animals that are at least 1 month, 3 weeks old.

Hope that helps,

VioVet